Remed Co.,Ltd. (KOSDAQ:302550)
2,890.00
-70.00 (-2.36%)
At close: May 29, 2026
Remed Market Cap
Remed has a market cap or net worth of 89.32 billion as of June 1, 2026. Its market cap has decreased by -10.98% in one year.
Market Cap
89.32B
Enterprise Value
84.81B
Revenue
25.24B
Ranking
n/a
PE Ratio
95.50
Stock Price
2,890.00
Market Cap Chart
Since August 14, 2018, Remed's market cap has increased from 73.83B to 89.32B, an increase of 20.98%. That is a compound annual growth rate of 2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 89.32B | -5.86% |
| Dec 30, 2025 | 94.88B | -13.97% |
| Dec 30, 2024 | 110.30B | 10.60% |
| Dec 28, 2023 | 99.73B | 31.78% |
| Dec 29, 2022 | 75.68B | -53.48% |
| Dec 30, 2021 | 162.69B | -18.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 124.50B |
| SELVAS Healthcare | 90.14B |
| Hironic | 83.24B |
| Dynamic solution | 71.68B |
| QuantaMatrix | 63.02B |
| DRGEM | 55.35B |
| Noul Co.,Ltd. | 50.01B |
| Genoray | 48.22B |